Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Rev Invest Clin ; 49(4): 281-6, 1997.
Artigo em Espanhol | MEDLINE | ID: mdl-9707993

RESUMO

Shear-induced aggregation requires the platelet glycoprotein complexes (Gp), the von Willebrand factor (vWf) and ADP. The Bernard Soulier syndrome (BS) and the gray platelet syndrome (GPS) are platelet function defects characterized by absence of GP Ib/IX and alpha granules, respectively, with mucocutaneous hemorrhages, prolonged bleeding time (BT) and moderate thrombocytopenia in both syndromes. There are reports that desmopressin (DDAVP) shortens the BT in some patients with platelet dysfunction. The purpose of this study was to evaluate the response t(DDAVP) in four female patients (2 with GPS plus Marfan's disease and 2 BS). All had bleeding episodes, BTs > 10 minutes, platelet counts (PC) between 40-88 x 10(9)/L and defects in platelet aggregation. The DDAVP was administered at a dose of 0.3 microgram/kg in 15 to 30 mL of isotonic saline given by slow intravenous drip in 30 to 45 min. All patients were studied before and after DDAVP administration (BT, PC, platelet factor, mean platelet volume, factors F.VIII:C, FvW:Ag, FvW:RiC of, and platelet aggregation). After DDAVP infusion the patients had a BT < 6 min, and increased levels of F. VIII:C, FvW:Ag and FvW:RiC of (> 100 Ul/dL), and the bleeding disappeared. We conclude that there was a good response to DDAVP probably associated with improved platelet adhesion, and increases in the multimers of the von Willebrand factor.


Assuntos
Síndrome de Bernard-Soulier/tratamento farmacológico , Desamino Arginina Vasopressina/uso terapêutico , Adolescente , Adulto , Síndrome de Bernard-Soulier/sangue , Síndrome de Bernard-Soulier/complicações , Síndrome de Bernard-Soulier/genética , Biopolímeros , Tempo de Sangramento , Desamino Arginina Vasopressina/farmacologia , Avaliação de Medicamentos , Feminino , Humanos , Síndrome de Marfan/complicações , Pessoa de Meia-Idade , Adesividade Plaquetária/efeitos dos fármacos , Agregação Plaquetária/efeitos dos fármacos , Deficiência do Pool Plaquetário/sangue , Deficiência do Pool Plaquetário/complicações , Deficiência do Pool Plaquetário/genética , Estudos Prospectivos , Síndrome , Fator de von Willebrand/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...